Steroid alterations in Cushing’s disease persist after remission: ACTH-driven steroid changes dissociate from mood-regulatory neurosteroids - Top-Institutions - MDSpire

Steroid alterations in Cushing’s disease persist after remission: ACTH-driven steroid changes dissociate from mood-regulatory neurosteroids

  • By

  • Sebnem Burhan

  • Ebubekir Akpinar

  • Sevim Eyupoglu

  • Ayhan Bingol

  • Merve Korkmaz Yilmaz

  • Aslihan Pekmezci

  • Ebru Turgal

  • Huseyin Sehit Burhan

  • Mutlu Niyazoglu

  • Esra Suheda Hatipoglu

  • July 2, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    tertiary endocrinology center
    tertiary endocrinology center

    Unknown, Unknown

    Key Differentiators

    • Endocrinology

  • #2

    endocrine tertiary care center
    endocrine tertiary care center

    Unknown, Unknown

    Key Differentiators

    • Endocrinology

  • #3

    single center
    single center

    Unknown, Unknown

    Key Differentiators

    • Endocrinology

  • #4

    two tertiary academic medical centers
    two tertiary academic medical centers

    Unknown, Unknown

    Key Differentiators

    • Endocrinology

  • #5

    University Hospital LMU Munich
    University Hospital LMU Munich

    Munich, Bavaria

    Key Differentiators

    • Endocrinology

Original Source(s)

Steroid alterations in Cushing’s disease persist after remission: ACTH-driven steroid changes dissociate from mood-regulatory neurosteroids

  • by Sebnem Burhan, Ebubekir Akpinar, Sevim Eyupoglu, Ayhan Bingol, Merve Korkmaz Yilmaz, Aslihan Pekmezci, Ebru Turgal, Huseyin Sehit Burhan, Mutlu Niyazoglu, Esra Suheda Hatipoglu

  • July 2, 2026

Related Content

Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction

Insulin resistance as a predictor of long-term adverse cardiovascular event risk in patients with atrial fibrillation following radiofrequency catheter ablation

Non-invasive biomarkers in assisted reproductive technologies, current evidence, clinical utility and future perspectives